Concepts (159)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Dual-Specificity Phosphatases | 2 | 2012 | 6 | 0.700 |
Why?
|
| Guanine Nucleotide Exchange Factors | 2 | 2012 | 76 | 0.460 |
Why?
|
| Lipopolysaccharides | 3 | 2013 | 301 | 0.390 |
Why?
|
| Platelet Aggregation | 1 | 2011 | 43 | 0.380 |
Why?
|
| Blood Platelets | 1 | 2011 | 149 | 0.360 |
Why?
|
| Acute Lung Injury | 1 | 2012 | 66 | 0.360 |
Why?
|
| Microvessels | 1 | 2009 | 72 | 0.310 |
Why?
|
| Sepsis | 1 | 2012 | 351 | 0.280 |
Why?
|
| Reactive Oxygen Species | 4 | 2012 | 505 | 0.240 |
Why?
|
| Mice | 12 | 2022 | 12133 | 0.200 |
Why?
|
| Phosphorylation | 4 | 2015 | 1142 | 0.200 |
Why?
|
| Mice, Knockout | 6 | 2012 | 2095 | 0.200 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2022 | 60 | 0.180 |
Why?
|
| Neutrophils | 2 | 2015 | 323 | 0.170 |
Why?
|
| Calcium Channels | 1 | 2002 | 182 | 0.170 |
Why?
|
| Superoxides | 2 | 2012 | 76 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2011 | 125 | 0.170 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2012 | 364 | 0.170 |
Why?
|
| Administrative Claims, Healthcare | 2 | 2016 | 3 | 0.160 |
Why?
|
| Islets of Langerhans | 1 | 2002 | 555 | 0.150 |
Why?
|
| Animals | 13 | 2022 | 28045 | 0.140 |
Why?
|
| TRPM Cation Channels | 2 | 2011 | 9 | 0.140 |
Why?
|
| Insulin | 1 | 2002 | 1167 | 0.130 |
Why?
|
| Laboratories, Hospital | 1 | 2016 | 8 | 0.130 |
Why?
|
| Risk Adjustment | 1 | 2016 | 40 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2015 | 6 | 0.120 |
Why?
|
| Integrin beta1 | 1 | 2015 | 34 | 0.120 |
Why?
|
| Phagocytosis | 2 | 2015 | 93 | 0.120 |
Why?
|
| Ovarian Neoplasms | 1 | 2022 | 787 | 0.120 |
Why?
|
| Membrane Proteins | 1 | 2002 | 1242 | 0.120 |
Why?
|
| Myosin-Light-Chain Phosphatase | 1 | 2015 | 9 | 0.120 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2015 | 86 | 0.120 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2015 | 39 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2013 | 7 | 0.110 |
Why?
|
| Endothelium, Vascular | 2 | 2013 | 437 | 0.110 |
Why?
|
| Endotoxemia | 1 | 2013 | 19 | 0.110 |
Why?
|
| Heart Diseases | 1 | 2016 | 308 | 0.110 |
Why?
|
| HEK293 Cells | 2 | 2015 | 667 | 0.110 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 212 | 0.100 |
Why?
|
| NADPH Oxidases | 2 | 2012 | 84 | 0.100 |
Why?
|
| Gene Deletion | 2 | 2015 | 354 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 183 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 4 | 2012 | 3375 | 0.100 |
Why?
|
| Endotoxins | 1 | 2012 | 38 | 0.100 |
Why?
|
| Bleeding Time | 1 | 2011 | 3 | 0.100 |
Why?
|
| 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 1 | 2011 | 8 | 0.100 |
Why?
|
| Hemostasis | 1 | 2011 | 22 | 0.090 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 49 | 0.090 |
Why?
|
| Phagocytes | 1 | 2011 | 14 | 0.090 |
Why?
|
| Capillary Permeability | 1 | 2012 | 133 | 0.090 |
Why?
|
| Thrombin | 1 | 2011 | 60 | 0.090 |
Why?
|
| Interferon-beta | 1 | 2012 | 126 | 0.090 |
Why?
|
| Cell Movement | 1 | 2015 | 801 | 0.090 |
Why?
|
| Cytoplasmic Granules | 1 | 2011 | 99 | 0.090 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2011 | 112 | 0.090 |
Why?
|
| Interleukin-10 | 1 | 2012 | 160 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2013 | 439 | 0.090 |
Why?
|
| MAP Kinase Signaling System | 1 | 2012 | 200 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2012 | 227 | 0.090 |
Why?
|
| Chemokine CCL3 | 1 | 2010 | 13 | 0.090 |
Why?
|
| Chemokine CCL4 | 1 | 2010 | 10 | 0.090 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2011 | 137 | 0.090 |
Why?
|
| Bone Marrow Cells | 1 | 2012 | 267 | 0.090 |
Why?
|
| Adenosine Triphosphate | 1 | 2011 | 319 | 0.090 |
Why?
|
| Thrombosis | 1 | 2013 | 312 | 0.090 |
Why?
|
| beta Catenin | 1 | 2012 | 266 | 0.090 |
Why?
|
| Nitric Oxide | 1 | 2012 | 283 | 0.080 |
Why?
|
| Pneumonia | 1 | 2012 | 187 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2011 | 698 | 0.080 |
Why?
|
| Insulysin | 1 | 2010 | 67 | 0.080 |
Why?
|
| Blotting, Western | 1 | 2011 | 794 | 0.080 |
Why?
|
| Collagen | 1 | 2011 | 303 | 0.080 |
Why?
|
| Transfection | 1 | 2011 | 901 | 0.080 |
Why?
|
| Signal Transduction | 4 | 2015 | 3508 | 0.080 |
Why?
|
| Inflammation | 2 | 2015 | 1025 | 0.080 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2012 | 403 | 0.080 |
Why?
|
| Escherichia coli | 1 | 2012 | 614 | 0.080 |
Why?
|
| Macrophages | 1 | 2012 | 601 | 0.070 |
Why?
|
| Cytokines | 1 | 2012 | 843 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2011 | 1938 | 0.070 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1164 | 0.070 |
Why?
|
| Genotype | 1 | 2011 | 1865 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2012 | 2907 | 0.070 |
Why?
|
| Protein Binding | 3 | 2015 | 1514 | 0.060 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 1594 | 0.060 |
Why?
|
| Percutaneous Coronary Intervention | 2 | 2016 | 71 | 0.060 |
Why?
|
| Lung | 1 | 2012 | 1337 | 0.060 |
Why?
|
| Phenotype | 1 | 2011 | 2502 | 0.060 |
Why?
|
| Humans | 12 | 2022 | 92303 | 0.060 |
Why?
|
| Cell Line | 3 | 2015 | 2506 | 0.050 |
Why?
|
| Coronary Artery Bypass | 2 | 2016 | 245 | 0.050 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 2007 | 0.050 |
Why?
|
| Patient Discharge | 2 | 2016 | 339 | 0.050 |
Why?
|
| Calcium | 2 | 2011 | 1183 | 0.050 |
Why?
|
| Myocardial Infarction | 2 | 2016 | 402 | 0.050 |
Why?
|
| Length of Stay | 2 | 2016 | 791 | 0.050 |
Why?
|
| Cations | 1 | 2002 | 31 | 0.050 |
Why?
|
| Insulinoma | 1 | 2002 | 38 | 0.050 |
Why?
|
| TRPC Cation Channels | 1 | 2002 | 23 | 0.050 |
Why?
|
| NAD | 1 | 2022 | 92 | 0.050 |
Why?
|
| Gene Library | 1 | 2002 | 134 | 0.050 |
Why?
|
| Tryptophan | 1 | 2022 | 103 | 0.050 |
Why?
|
| Cloning, Molecular | 1 | 2002 | 643 | 0.040 |
Why?
|
| Ion Channels | 1 | 2002 | 251 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 1 | 2002 | 1052 | 0.040 |
Why?
|
| Amino Acid Sequence | 2 | 2015 | 2075 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2022 | 786 | 0.040 |
Why?
|
| Tumor Microenvironment | 1 | 2022 | 521 | 0.040 |
Why?
|
| Gene Expression | 1 | 2002 | 1315 | 0.030 |
Why?
|
| Kidney | 1 | 2002 | 1145 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2002 | 2037 | 0.030 |
Why?
|
| Heart Failure | 2 | 2016 | 1346 | 0.030 |
Why?
|
| Cricetulus | 1 | 2015 | 128 | 0.030 |
Why?
|
| CHO Cells | 1 | 2015 | 189 | 0.030 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2015 | 88 | 0.030 |
Why?
|
| cdc42 GTP-Binding Protein | 1 | 2015 | 13 | 0.030 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2015 | 17 | 0.030 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2015 | 26 | 0.030 |
Why?
|
| Male | 3 | 2015 | 43924 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2015 | 30 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2015 | 56 | 0.030 |
Why?
|
| Cell Culture Techniques | 1 | 2015 | 200 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2015 | 431 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 250 | 0.030 |
Why?
|
| Female | 2 | 2022 | 47894 | 0.030 |
Why?
|
| Platelet Adhesiveness | 1 | 2013 | 9 | 0.030 |
Why?
|
| RNA Interference | 1 | 2015 | 384 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2013 | 40 | 0.030 |
Why?
|
| Hospital Mortality | 1 | 2016 | 444 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2016 | 8727 | 0.030 |
Why?
|
| HL-60 Cells | 1 | 2012 | 25 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2016 | 578 | 0.020 |
Why?
|
| Toll-Like Receptor 3 | 1 | 2012 | 11 | 0.020 |
Why?
|
| Macrophages, Peritoneal | 1 | 2012 | 24 | 0.020 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2013 | 159 | 0.020 |
Why?
|
| Luciferases | 1 | 2012 | 129 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 173 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2013 | 559 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 284 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 1764 | 0.020 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2010 | 10 | 0.020 |
Why?
|
| Polymerization | 1 | 2010 | 34 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2011 | 402 | 0.020 |
Why?
|
| Membrane Potentials | 1 | 2011 | 436 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 1016 | 0.020 |
Why?
|
| Peptides | 1 | 2013 | 656 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 926 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 184 | 0.020 |
Why?
|
| Lung Diseases | 1 | 2011 | 283 | 0.020 |
Why?
|
| Crystallography, X-Ray | 1 | 2010 | 508 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2012 | 708 | 0.020 |
Why?
|
| Protein Conformation | 1 | 2010 | 902 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 1337 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2010 | 3018 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 5705 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2016 | 6916 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2012 | 2448 | 0.010 |
Why?
|
| Mutation | 1 | 2010 | 4210 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 19952 | 0.010 |
Why?
|